Business of Optometry News

The FDA cleared an investigational new drug application for OpCT-001, an investigational cell therapy for the treatment of primary photoreceptor diseases, according to a press release from BlueRock Therapeutics.

Retirement planning for physicians is a critical aspect of financial management, given the unique challenges and opportunities they face.

CARLSBAD, Calif. — In this Healio Video Perspective from the Women in Ophthalmology Summer Symposium, Cari Stone of Elios Vision previews the company’s excimer laser for the treatment of glaucoma.

CARLSBAD, Calif. — In this Healio Video Perspective from the Women in Ophthalmology Summer Symposium, Carole C. Foos, CPA, of OJM Group discusses saving and investing pearls for ophthalmologists.

The European Commission granted marketing authorization to Akantior for the treatment of Acanthamoeba keratitis, according to a press release from Avanzanite Bioscience.

The Vision Council has launched The Vision Council Foundation, a philanthropic arm that aims to bridge the gap between industry, eye care providers and consumers through educational programs, research and other opportunities.

Most physicians receive a regular paycheck, and sometimes receive a lump sum such as a bonus. A proportion of both should be invested. How should one invest a portion of their regular paycheck?

Three-quarters of eye care providers report that inflation has directly affected their practice in 2024, according to new data from The Vision Council.

Opus Genetics received rare pediatric disease designation from the FDA for its ocular gene therapy designed to treat patients with a form of Leber congenital amaurosis, according to a press release.

Visiox Pharmaceuticals has entered into a definitive merger agreement with Ocuvex Therapeutics, according to a press release.